Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Nurix Therapeutics, Inc. (NRIX) is a Biotechnology company based in US with a market capitalization of $1.5B. Revenue grew 54.0% year-over-year and free cash flow was negative at -$263.5M. This page tracks NRIX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 286 employees · IPO Jul 24, 2020
Valuation
Valuation & price
$15.86as of May 17, 2026· -34.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.87
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.5B
Market cap
54.0%
Revenue growth (YoY)
77.5%
Gross margin
-$263.5M
Free cash flow (USD)
-$537.2M
Net debt
Net cash position
29.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
10
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 2, 2026Filing
Insider Sell $259K · 10b5-1 PlanRing Christine · Chief Legal Officer · $259.4K
- Insider sellJun 25, 2026Filing
Insider Sell $108K · 10b5-1 PlanHansen Gwenn · Chief Scientific Officer · $107.9K
- Insider sellJun 25, 2026Filing
Insider Sell $581K · 10b5-1 PlanRing Christine · Chief Legal Officer · $580.5K
- 8-K eventJun 11, 2026Filing
Clinical Data Update
- 8-K eventJun 8, 2026Filing
Collaboration Agreement
- Insider sellJun 2, 2026Filing
Insider Sell $135K · 10b5-1 PlanRing Christine · Chief Legal Officer · $135.3K
- 8-K eventMay 15, 2026Filing
Annual Meeting Results
- Insider sellMay 5, 2026Filing
Insider Sell $233K · 10b5-1 Planvan Houte Hans · Chief Financial Officer · $233.3K
- Insider sellMay 4, 2026Filing
Insider Sell $138K · 10b5-1 PlanRing Christine · Chief Legal Officer · $138.2K
- Insider sellMay 1, 2026Filing
Insider Sell $90K · 10b5-1 PlanRing Christine · Chief Legal Officer · $90.4K
Questions
Frequently asked questions
What is Nurix Therapeutics, Inc.'s market cap?
Nurix Therapeutics, Inc. (NRIX) has a market capitalization of $1.5B.
What is NRIX's P/E ratio?
A meaningful P/E ratio is not available for NRIX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is NRIX's price-to-book (P/B) ratio?
NRIX trades at 2.87 times book value per share.
Are insiders buying NRIX stock?
SEC Form 4 filings show no open-market insider buys at Nurix Therapeutics, Inc. in the last 90 days (10 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.